STATERA BIOPHARMA INC's ticker is and the CUSIP is 857561104. A total of 30 filers reported holding STATERA BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,300 | – | 28,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 366,460 | $847,000 | 0.11% |
| Virtu Financial LLC | 13,185 | $30,000 | 0.00% |
| DOWLING & YAHNKE LLC | 14,675 | $34,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 72,025 | $166,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 13,891 | $32,000 | 0.00% |
| Renaissance Technologies | 114,198 | $264,000 | 0.00% |
| VANGUARD GROUP INC | 426,341 | $984,000 | 0.00% |
| UBS Group AG | 19,470 | $45,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 290 | $1,000 | 0.00% |
| FMR LLC | 46 | $0 | 0.00% |